274 related articles for article (PubMed ID: 16187022)
1. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
[TBL] [Abstract][Full Text] [Related]
2. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
3. Interferon regulatory factor-1 mediates interferon-gamma-induced apoptosis in ovarian carcinoma cells.
Kim EJ; Lee JM; Namkoong SE; Um SJ; Park JS
J Cell Biochem; 2002; 85(2):369-80. PubMed ID: 11948692
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
[TBL] [Abstract][Full Text] [Related]
5. Combination of all-trans retinoic acid and interferon-gamma suppressed PI3K/Akt survival pathway in glioblastoma T98G cells whereas NF-kappaB survival signaling in glioblastoma U87MG cells for induction of apoptosis.
Zhang R; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2194-202. PubMed ID: 17616812
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral interferon regulatory factor (IRF)-1 but not IRF-2 is of relevance in predicting patient outcome in ovarian cancer.
Zeimet AG; Reimer D; Wolf D; Fiegl H; Concin N; Wiedemair A; Wolf AM; Rumpold H; Müller-Holzner E; Marth C
Int J Cancer; 2009 May; 124(10):2353-60. PubMed ID: 19170204
[TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
[TBL] [Abstract][Full Text] [Related]
8. Growth of astrocytomas in the human tumor clonogenic assay and sensitivity to mismatched dsRNA and interferons.
Strayer DR; Weisband J; Carter WA; Black P; Nidzgorski F; Cook AW
Am J Clin Oncol; 1987 Aug; 10(4):281-4. PubMed ID: 3039828
[TBL] [Abstract][Full Text] [Related]
9. Two different mechanisms of apoptosis resistance observed in interferon-beta induced apoptosis of human glioma cells.
Saito R; Mizuno M; Hatano M; Kumabe T; Yoshimoto T; Yoshida J
J Neurooncol; 2004 May; 67(3):273-80. PubMed ID: 15164982
[TBL] [Abstract][Full Text] [Related]
10. Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells.
Karmakar S; Banik NL; Patel SJ; Ray SK
Neurosci Lett; 2006 Oct; 407(1):53-8. PubMed ID: 16949208
[TBL] [Abstract][Full Text] [Related]
11. Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
Stang MT; Armstrong MJ; Watson GA; Sung KY; Liu Y; Ren B; Yim JH
Oncogene; 2007 Sep; 26(44):6420-30. PubMed ID: 17452973
[TBL] [Abstract][Full Text] [Related]
12. IRF-1 is an essential mediator in IFN-gamma-induced cell cycle arrest and apoptosis of primary cultured hepatocytes.
Kano A; Haruyama T; Akaike T; Watanabe Y
Biochem Biophys Res Commun; 1999 Apr; 257(3):672-7. PubMed ID: 10208842
[TBL] [Abstract][Full Text] [Related]
13. Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.
Luo XM; Ross AC
J Biol Chem; 2005 Oct; 280(43):36228-36. PubMed ID: 16085646
[TBL] [Abstract][Full Text] [Related]
14. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
[TBL] [Abstract][Full Text] [Related]
15. The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
Yim JH; Ro SH; Lowney JK; Wu SJ; Connett J; Doherty GM
J Interferon Cytokine Res; 2003 Sep; 23(9):501-11. PubMed ID: 14565859
[TBL] [Abstract][Full Text] [Related]
16. Pegylated IFN-α sensitizes melanoma cells to chemotherapy and causes premature senescence in endothelial cells by IRF-1 mediated signaling.
Upreti M; Koonce NA; Hennings L; Chambers TC; Griffin RJ
Cell Death Dis; 2010; 1(8):e67. PubMed ID: 21197417
[TBL] [Abstract][Full Text] [Related]
17. Interferon regulatory factor (IRF)-1 and IRF-2 are associated with prognosis and tumor invasion in HCC.
Yi Y; Wu H; Gao Q; He HW; Li YW; Cai XY; Wang JX; Zhou J; Cheng YF; Jin JJ; Fan J; Qiu SJ
Ann Surg Oncol; 2013 Jan; 20(1):267-76. PubMed ID: 22805863
[TBL] [Abstract][Full Text] [Related]
18. Role of IRF-1 and caspase-7 in IFN-gamma enhancement of Fas-mediated apoptosis in ACHN renal cell carcinoma cells.
Tomita Y; Bilim V; Hara N; Kasahara T; Takahashi K
Int J Cancer; 2003 Apr; 104(4):400-8. PubMed ID: 12584735
[TBL] [Abstract][Full Text] [Related]
19. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers.
Wang Y; Liu DP; Chen PP; Koeffler HP; Tong XJ; Xie D
Cancer Res; 2007 Mar; 67(6):2535-43. PubMed ID: 17363571
[TBL] [Abstract][Full Text] [Related]
20. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
